HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Radiosensitization of human tumor HeLa cells induced by methyl ester of 6-oxo-6-[2,2-ethylenedioxy-5-(dimethoxycarbonylmethyl)-cyclope nt- 1-yL]-hexanoic acid].

Abstract
Methyl ester of 6-oxo-6-[2,2-ethylenedioxy-5-(dimethoxycarbonylmethyl)- cyclopent-1-yl]-hexanoic acid (7-keto-9,9-ethylenedioxiprostanoid, that is analogue of 11-deoxy-PGE1 with modified chains) at concentration 10(-6) mol/l displayed maximal (25%) sensitizing effect when was tested in a range of concentrations 10(-7)-10(-5) mol/l and HeLa cells were gamma-irradiated at dose of 2 Gy, that was compared with metronidazol action. Optimal time of prostanoid contact with cells was between 30 and 60 min, and metronidazol--60 min. Prostanoid effect was exhibited at irradiation doses from 2 to 4 Gy and reached maximum of 46% at 4 Gy, its DMF was 1.5 as well as that of metronidazol. Cytotoxicity of comparable compounds was approximately equal. By its chemical structure and sensitizing features this 7-keto-9,9-ethylenedioxiprostanoid is a prototype of new radiosensitizing drug.
AuthorsI G Dad'kov, B B Kuz'mitskiĭ, I P Antonevich, F A Lakhvich
JournalRadiatsionnaia biologiia, radioecologiia (Radiats Biol Radioecol) 2000 Mar-Apr Vol. 40 Issue 2 Pg. 204-7 ISSN: 0869-8031 [Print] Russia (Federation)
Vernacular TitleRadiosensibilizatsiia kletok HeLa opukholi cheloveka pod vliianiem metilovogo éfira 6-okso-6-[2,2-étilendioksi-5-(dimetoksikarbonilmetil)- tsiklopent-1-il]-geksanovoĭ kisloty.
PMID10819046 (Publication Type: Journal Article)
Chemical References
  • 7-keto-9,9-ethylenedioxiprostanoid
  • Radiation-Sensitizing Agents
  • Alprostadil
  • 11-deoxyprostaglandin E1
Topics
  • Alprostadil (analogs & derivatives, chemistry, pharmacology)
  • HeLa Cells (drug effects, radiation effects)
  • Humans
  • Radiation Tolerance (drug effects)
  • Radiation-Sensitizing Agents (chemistry, pharmacology)
  • Radiotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: